Shambhavi Naik, Yazad Jal and Anirudh Kanisetti discuss the contentious issue of germline gene editing.
Eminent scientists have called for a five year moratorium on clinical applications of germline (concerning reproductive cells) gene editing. Such a move will reduce funding and transnational research in congenital diseases.
In this episode, they discuss how proposing stringent safety standards would be more effective than an outright ban.
Subscribe and listen to the podcast on:
or any other podcast app.